Maternal and Early-Life Exposure to Antibiotics and the Risk of Autism and Attention-Deficit Hyperactivity Disorder in Childhood: a Swedish Population-Based Cohort Study.
Child
Pregnancy
Female
Humans
Attention Deficit Disorder with Hyperactivity
/ chemically induced
Cohort Studies
Autistic Disorder
/ chemically induced
Anti-Bacterial Agents
/ adverse effects
Sweden
/ epidemiology
Prenatal Exposure Delayed Effects
/ chemically induced
Maternal Exposure
/ adverse effects
Journal
Drug safety
ISSN: 1179-1942
Titre abrégé: Drug Saf
Pays: New Zealand
ID NLM: 9002928
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
accepted:
19
03
2023
medline:
8
5
2023
pubmed:
23
4
2023
entrez:
23
04
2023
Statut:
ppublish
Résumé
Antibiotics represent the most common type of medication used during pregnancy and infancy. Antibiotics have been proposed as a possible factor in changes in microbiota composition, which may play a role in the aetiology of autism and attention deficit/hyperactivity disorder (ADHD). Our aim was to investigate the association between maternal and early-life antibiotic use and autism and ADHD in childhood. This Swedish nation-wide population-based cohort study included all first live singleton births (N = 483,459) between January 2006 and December 2016. The association of dispensed antibiotics with autism and ADHD in children aged ≤ 11 years was estimated by applying multivariable logistic regression and generalised estimating equations models. Of the mothers, 25.9% (n = 125,106) were dispensed ≥1 antibiotic during the exposure period (from 3 months pre-conception to delivery), and 41.6% (n = 201,040) of the children received ≥ 1 antibiotic in early life (aged ≤ 2 years). Penicillin was the most prescribed antibiotic class (17.9% of mothers, 38.2% of children). Maternal antibiotic use was associated with an increased risk of autism [odds ratio (OR) = 1.16, 95% confidence interval (CI) 1.09-1.23] and ADHD (OR = 1.29, 95% CI 1.21-1.36) in childhood. Early-life exposure to antibiotics showed an even stronger association [autism (OR = 1.46, 95% CI 1.38-1.55); ADHD (OR = 1.90, 95% CI 1.80-2.00)]. Both maternal and childhood-exposure sub-analyses suggested a dose-response relationship. Maternal and early-life antibiotic use was associated with an increased risk of autism and ADHD in childhood. However, differences were noted by exposure period and antibiotic classes. Antibiotics are commonly prescribed to pregnant women, infants, and toddlers. Antibiotic use during pregnancy may alter the maternal microbiota, which can influence the microbial colonisation of the gastrointestinal system of the foetus. It has been claimed that antibiotic use during pregnancy may have an effect on the gut-brain axis and, as a result, neurodevelopment. Neurodevelopmental disorder (NDD) is a category of illnesses characterised by functional impairments that manifest early in development. The most frequent NDDs are autism and attention-deficit/hyperactivity disorder (ADHD). In this large Swedish nation-wide study, we assessed whether antibiotic use during pregnancy and/or early in life affects the risk of developing autism and ADHD. The study found that both maternal antibiotic usage, as well as early childhood antibiotic use, were associated with an increased risk of autism and ADHD in children. These associations were altered by the quantity, type, and timing of antibiotic exposure.
Autres résumés
Type: plain-language-summary
(eng)
Antibiotics are commonly prescribed to pregnant women, infants, and toddlers. Antibiotic use during pregnancy may alter the maternal microbiota, which can influence the microbial colonisation of the gastrointestinal system of the foetus. It has been claimed that antibiotic use during pregnancy may have an effect on the gut-brain axis and, as a result, neurodevelopment. Neurodevelopmental disorder (NDD) is a category of illnesses characterised by functional impairments that manifest early in development. The most frequent NDDs are autism and attention-deficit/hyperactivity disorder (ADHD). In this large Swedish nation-wide study, we assessed whether antibiotic use during pregnancy and/or early in life affects the risk of developing autism and ADHD. The study found that both maternal antibiotic usage, as well as early childhood antibiotic use, were associated with an increased risk of autism and ADHD in children. These associations were altered by the quantity, type, and timing of antibiotic exposure.
Identifiants
pubmed: 37087706
doi: 10.1007/s40264-023-01297-1
pii: 10.1007/s40264-023-01297-1
pmc: PMC10164008
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
467-478Informations de copyright
© 2023. The Author(s).
Références
Autism. 2022 Nov;26(8):2108-2116
pubmed: 35257591
Pediatr Res. 2020 Sep;88(3):438-443
pubmed: 31954376
Mayo Clin Proc. 2021 Jan;96(1):66-77
pubmed: 33208243
Rev J Autism Dev Disord. 2021;8(4):454-470
pubmed: 34868805
Transl Psychiatry. 2019 Nov 26;9(1):317
pubmed: 31772217
Reprod Biol Endocrinol. 2022 Feb 7;20(1):30
pubmed: 35130922
Am J Epidemiol. 1986 Nov;124(5):816-25
pubmed: 3532767
Dev Psychopathol. 2021 Oct;33(4):1448-1495
pubmed: 32703331
FEMS Microbiol Rev. 2018 Jul 1;42(4):489-499
pubmed: 29945240
World J Pediatr. 2022 May;18(5):308-319
pubmed: 35235183
Nat Rev Microbiol. 2009 Dec;7(12):887-94
pubmed: 19898491
Lancet Neurol. 2020 Feb;19(2):179-194
pubmed: 31753762
J Am Acad Child Adolesc Psychiatry. 2012 May;51(5):467-476.e6
pubmed: 22525953
Pharmacoepidemiol Drug Saf. 2013 Jul;22(7):691-9
pubmed: 23703712
Psychol Med. 2021 Oct;51(13):2260-2273
pubmed: 33634770
BMC Med. 2016 Jun 17;14(1):91
pubmed: 27312712
Gut Microbes. 2020 Sep 2;11(5):1172-1187
pubmed: 32329656
Epidemiology. 2019 Jan;30(1):52-60
pubmed: 30273187
Psychol Med. 2021 Oct;51(13):2274-2286
pubmed: 33814023
CMAJ. 2020 May 19;192(20):E527-E535
pubmed: 32575031
Eur J Clin Pharmacol. 2014 Jun;70(6):757-63
pubmed: 24756147
J Antimicrob Chemother. 2022 Apr 27;77(5):1461-1467
pubmed: 35233608
Clin Microbiol Infect. 2014 Jul;20(7):629-35
pubmed: 24118384
Clin Epidemiol. 2011 Feb 01;3:43-50
pubmed: 21386973
Nat Med. 2016 Oct 06;22(10):1079-1089
pubmed: 27711063
Lancet. 2018 Oct 13;392(10155):1349-1357
pubmed: 30322585
PLoS One. 2022 Mar 10;17(3):e0265204
pubmed: 35271648
Chemotherapy. 2016;61(3):134-43
pubmed: 26780532
Eur J Epidemiol. 2017 Sep;32(9):765-773
pubmed: 28983736
J Autism Dev Disord. 2019 Sep;49(9):3866-3876
pubmed: 31175505
PLoS One. 2012;7(7):e41280
pubmed: 22911770
BMJ. 2015 Apr 28;350:h1961
pubmed: 25922345
Drug Metab Dispos. 2015 Oct;43(10):1557-71
pubmed: 25852213
Int J Epidemiol. 2018 Oct 1;47(5):1724
pubmed: 29860299
World J Gastroenterol. 2020 Nov 14;26(42):6626-6637
pubmed: 33268951
BMC Neurosci. 2021 Oct 9;22(1):60
pubmed: 34627165
Source Code Biol Med. 2008 Dec 16;3:17
pubmed: 19087314
World J Clin Pediatr. 2021 May 9;10(3):15-28
pubmed: 33972922
Res Child Adolesc Psychopathol. 2021 Mar;49(3):297-310
pubmed: 33492530
Trends Mol Med. 2014 Sep;20(9):509-18
pubmed: 24956966
BMJ Open. 2021 Dec 8;11(12):e050569
pubmed: 34880014
Pharmacoepidemiol Drug Saf. 2018 Jan;27(1):105-113
pubmed: 29171114
Acta Biomed. 2020 Nov 09;91(13-S):e2020003
pubmed: 33170170
J Autism Dev Disord. 2022 May;52(5):2236-2246
pubmed: 34081300
BMC Public Health. 2011 Jun 09;11:450
pubmed: 21658213
Scand J Soc Med. 1990 Jun;18(2):143-8
pubmed: 2367825
Prim Care Companion CNS Disord. 2014;16(3):
pubmed: 25317366
Pathogens. 2022 Jan 31;11(2):
pubmed: 35215136
Nature. 2016 Jan 14;529(7585):212-5
pubmed: 26762459
Pharmacoepidemiol Drug Saf. 2007 Jul;16(7):726-35
pubmed: 16897791